166 related articles for article (PubMed ID: 2676535)
21. Class III antiarrhythmic agents: the next wave.
Bauman JL
Pharmacotherapy; 1997; 17(2 Pt 2):76S-83S; discussion 89S-91S. PubMed ID: 9085343
[TBL] [Abstract][Full Text] [Related]
22. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P;
Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008
[TBL] [Abstract][Full Text] [Related]
24. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
[TBL] [Abstract][Full Text] [Related]
25. [Cardiac arrhythmia in moderate arterial hypertension. Epidemiologic survey of 251 cases. Effect of sotalol].
Clémenty J; Safar M; Vrancea F
Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):47-51. PubMed ID: 2648967
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of long-term treatment with amiodarone for life-threatening arrhythmias.
Burckhardt D
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S59-62. PubMed ID: 1279310
[TBL] [Abstract][Full Text] [Related]
27. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
[TBL] [Abstract][Full Text] [Related]
28. [Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period].
Fournier C; Brunet M; Kindermans M; Fedorowsky A; Tournadre P; Gensous D; Blondeau M
Arch Mal Coeur Vaiss; 1989 Jan; 82(1):69-77. PubMed ID: 2494973
[TBL] [Abstract][Full Text] [Related]
29. Effects of sotalol in twenty patients with cardiac arrhythmias.
Latour Y; Dumont G; Brosseau A; LeLorier J
Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):275-8. PubMed ID: 881280
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of sotalol for life-threatening ventricular arrhythmias.
Roden DM
Am J Cardiol; 1993 Aug; 72(4):51A-55A. PubMed ID: 8346727
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
Gonzalez R; Scheinman MM; Herre JM; Griffin JC; Sauve MJ; Sharkey H
J Am Coll Cardiol; 1988 Dec; 12(6):1568-72. PubMed ID: 3192854
[TBL] [Abstract][Full Text] [Related]
32. Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
Kovoor P; Eipper V; Byth K; Cooper MJ; Uther JB; Ross DL
Eur Heart J; 1999 Mar; 20(5):364-74. PubMed ID: 10206383
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias.
Lee RJ; Wong M; Siu A; Namekawa-Wong M; Epstein LM; Fitzpatrick AP; Grogin HR; Scheinman MM; Lesh MD
Am Heart J; 1996 Nov; 132(5):973-8. PubMed ID: 8892770
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
[TBL] [Abstract][Full Text] [Related]
35. Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
Piccini JP; Al-Khatib SM; Wojdyla DM; Shaw LK; Horton JR; Lokhnygina Y; Anstrom KJ; DeWald T; Allen-LaPointe N; Steinberg BA; Thomas K; Daubert JP; Peterson ED
Am J Cardiol; 2014 Sep; 114(5):716-22. PubMed ID: 25129065
[TBL] [Abstract][Full Text] [Related]
36. [Monitoring the effectiveness of amiodarone in the treatment of ventricular ectopic arrhythmias].
Pleskot M; Pidrman V; Tilser P
Cas Lek Cesk; 1989 Nov; 128(45):1417-20. PubMed ID: 2620330
[TBL] [Abstract][Full Text] [Related]
37. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
Leak D
Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of amiodarone in the treatment of refractory nonsustained ventricular tachycardia.
Ballas SL; Veltri EP
Md Med J; 1991 Jun; 40(6):475-8. PubMed ID: 1861575
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of antiarrhythmic therapy in dogs with naturally acquired tachyarrhythmias treated with amiodarone or sotalol: a retrospective analysis of 64 cases.
Romito G; Gemma N; Dondi F; Mazzoldi C; Fasoli S; Cipone M
J Vet Cardiol; 2024 Jun; 53():20-35. PubMed ID: 38608438
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.
Ruder MA; Ellis T; Lebsack C; Mead RH; Smith NA; Winkle RA
J Am Coll Cardiol; 1989 Jan; 13(1):145-52. PubMed ID: 2909562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
